GlassScriptPhysician profile
William Logan Dedmon
NPI 1871054668
$7,219.43
in general payments reported to CMS, 2019-2025
38 companies · $2,102 in 2025
The $2,102 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $384 · 2023: $2,324 · 2024: $2,410 · 2025: $2,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,835.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,007.82 | 2022-2025 | |
| Novo Nordisk INC | $988.20 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $810.61 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $693.13 | 2023-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $604.75 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $400.48 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $390.59 | 2022-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $249.32 | 2022-2025 | Spravato, Xarelto |
| Amgen INC. | $211.16 | 2023-2024 | Repatha, Otezla, Evenity |
| Xeris Pharmaceuticals, INC. | $196.25 | 2023-2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $164.27 | 2022-2025 | |
| Dexcom, INC. | $148.91 | 2022-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $140.81 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $140.51 | 2023-2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $118.33 | 2022-2024 | Eliquis, Camzyos |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dedmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.